The U.S. Food and Drug Administration (FDA) has cleared Sarepta Therapeutics to start dosing and screening in a first clinical trial testing the gene therapy SRP-9005 in people with limb-girdle ...
Sarepta Therapeutics SRPT announced updates from its clinical programs, which focus on targeting different subtypes of limb-girdle muscular dystrophy (LGMD), a group of rare genetic disorders marked ...
– U.S. FDA has confirmed that screening and dosing may proceed in Study SRP-9005-101 for LGMD2C/R5 – Enrollment and dosing completed in Study SRP-9004-102 for LGMD2D/R3 – Data expected for SRP-9003 ...
– Enrollment and dosing completed in Study SRP-9004-102 for LGMD2D/R3 – Data expected for SRP-9003 for LGMD2E/R4 by mid-2025 CAMBRIDGE, Mass., April 15, 2025--(BUSINESS WIRE)--Sarepta Therapeutics, ...
Powered by Zen 5 and Zen 5c microarchitectures, these processors offer everything from 8 cores to a whopping 192 cores, giving you plenty of options to match your workload. They come with different ...
AMD has just introduced the 5th Gen AMD EPYC Embedded 9005 Series “Zen 5” processors designed for embedded systems with a focus on longevity (7 years), reliability, and system resiliency, and ...
Advanced Micro Devices announced the expansion of its x86 embedded processor portfolio with the introduction of 5th Gen AMD Epyc Embedded processors. AMD Epyc Embedded 9005 Series CPUs are optimized ...
Hewlett Packard Enterprise (HPE) is expanding its ProLiant Gen11 server portfolio aimed at balancing performance with sustainability. With AMD EPYC processors at the core, the new lineup additions ...
New servers offer CPUs with leading 192 core count and memory processing for compute-intensive HPC and mixed-use AI workloads FREMONT, Calif.--(BUSINESS WIRE)--Penguin Solutions™, Inc. (Nasdaq: PENG) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback